Atlas Trials

Treatment of Newly Diagnosed Peripheral T-cell Lymphoma

Clinical trial NCT03631862 · UNKNOWN

Trial details

NCT number
NCT03631862
Sponsor
Zhengzhou University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Newly Diagnosed Peripheral T-cell Lymphoma
Start date
2018-09-01
Primary completion
2019-12-31
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.